Island Pharma aims to turn Galidesivir, its antiviral ace against Marburg, into reality – with the FDA’s November call to ...
Stockhead on MSN
Biocurious: Drug developers are hedging their bets on long and winding approval journey
Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.
Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024Dupixent® global net sales (recorded by Sanofi) increased 27% to $4.86 billion EYLEA HD® U.S. net sales increased 10% ...
MedPage Today on MSNOpinion
An Explosive Tragedy in Tennessee
One of the most important things to understand about explosions is that they uniquely maim and kill, causing devastating ...
Trump scrambles to rehire CDC experts working on Ebola, measles and disease forecasting who were axed in government shutdown ...
A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19 ...
The Outer Worlds 2 is good if you're in the mood for a fun but ultimately rather forgettable Avowed-style RPG romp, but not ...
The lead characters face many of the same interfaith relationship dilemmas, as Jenni Konner and Bruce Eric Kaplan take over ...
The Outer Worlds 2 is bigger and better than the first game in every respect, with deep, rich role-playing and plenty of ...
The Outer Worlds 2 's Metacritic score has landed and it's right on par with the original RPG, and tied for fifth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results